Doubly Robust Estimators of the Restricted Mean Time in Favor Estimands in Individual‐ and Cluster‐Randomized Trials
Statistics in Medicine · 2026-06 · 45 (13-14)
DOI: 10.1002/sim.70599 ↗Kurz gefasst
Fachartikel in der Zeitschrift Statistics in Medicine, online erschienen am 26.05.2026. Verfasst von Xi Fang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, Models, Statistical. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIA NIH HHS, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Progressive multi‐state survival outcomes are common in trials with recurrent or sequential events and require treatment effect estimands that remain interpretable without proportional intensity or Markov assumptions. The restricted mean time in favor of treatment (RMT‐IF) extends the restricted mean survival time to ordered multi‐state processes and provides such an interpretable estimand. However, existing RMT‐IF methods are nonparametric, assume covariate‐independent censoring for independent observations, and do not accommodate cluster‐randomized trials (CRTs), limiting both efficiency and applicability. We develop a class of doubly robust estimators for RMT‐IF under right censoring using an augmented inverse‐probability weighting framework that combines stage‐specific outcome regression with arm‐specific censoring models, yielding consistency when either nuisance model is correctly specified. We further extend the framework to CRTs by formalizing both cluster‐level and individual‐level average RMT‐IF estimands to address informative cluster size and by constructing corresponding doubly robust estimators that account for within‐cluster correlation. For inference, we employ model‐agnostic jackknife variance estimators in both individually randomized and cluster‐randomized settings. Extensive simulation studies demonstrate finite‐sample performance, and the methods are illustrated using two randomized trial examples.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut, USA.
- Center for Methods in Implementation and Prevention Science, Yale School of Public Health, New Haven, Connecticut, USA.
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
- Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, New Jersey, USA.
ORCID-Profile: Xi Fang, Guangyu Tong, Shuangge Ma, Fan Li
Förderung
- NHLBI NIH HHS
- NIA NIH HHS
- National Heart, Lung, and Blood Institute
Zitieren
APA
Fang, X., Wang, B., Tong, G., Hu, L., Ma, S., & Li, F. (2026). Doubly Robust Estimators of the Restricted Mean Time in Favor Estimands in Individual‐ and Cluster‐Randomized Trials. Statistics in Medicine, 45(13-14). https://doi.org/10.1002/sim.70599
Vancouver
Fang X, Wang B, Tong G, Hu L, Ma S, Li F. Doubly Robust Estimators of the Restricted Mean Time in Favor Estimands in Individual‐ and Cluster‐Randomized Trials. Statistics in Medicine. 2026;45(13-14). doi:10.1002/sim.70599
BibTeX
@article{Fang2026,
author = {Fang, Xi and Wang, Bingkai and Tong, Guangyu and Hu, Liangyuan and Ma, Shuangge and Li, Fan},
title = {Doubly Robust Estimators of the Restricted Mean Time in Favor Estimands in Individual‐ and Cluster‐Randomized Trials},
journal = {Statistics in Medicine},
year = {2026},
volume = {45},
number = {13-14},
doi = {10.1002/sim.70599}
}
EUVIMED